Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Glucocorticoids are among the most common therapeutic agents used in medical practice, yet their mechanisms of action are only partly understood. This review summarizes our understanding of how glucocorticoids inhibit inflammation and give rise to side effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NLRP3 inflammasome upregulation and caspase-mediated cleavage of the glucocorticoid receptor can cause resistance to the effects of glucocorticoids, which are among the most potent anti-inflammatory hormones in the body46,47.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [47]
In the citing paper
“HPA axis activation and subsequent secretion of glucocorticoids in response to stressor exposure typically acts to prevent pro-inflammatory activity via inhibition of NFκB (Rhen and Cidlowski, 2005).”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Rhen and Cidlowski, 2005
In the citing paper
“cortisol is one of the most potent anti-inflammatory hormones in the body.9”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [9]
In the citing paper
“major depression is a disorder that is characterized by hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis and increased release of glucocorticoids”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [9]
In the citing paper
“Corticosteroids (e.g., methylprednisolone, prednisolone, prednisone) are commonly used immunosuppressants for their global inhibitory effects on innate and adaptive immunity (36).”
From A versatile toolkit for overcoming AAV immunity (2022) · cites this paper as [36]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Retracted: Effects of Vitamin K2 on Osteoporosis
Iwamoto, J., Takeda, T., & Satō, Y. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383782 · Cited by 66
RetractedAngus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Epidemiology and estimated population burden of selected autoimmune diseases in the United States
Jacobson, D. L., Gange, S. J., Rose, N. R., & Graham, N. M. H. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4412 · Cited by 1,667
Regulation of matrix metalloproteinases: An overview
Chakraborti, S., Mandal, M., Das, S., Mandal, A., & Chakraborti, T. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1026028303196 · Cited by 1,128
Neuroendocrine Regulation of Immunity
Webster, J. I., Tonelli, L., & Sternberg, E. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.082401.104914 · Cited by 957
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898
The epidemiology of autoimmune diseases
Cooper, G. S., & Stroehla, B. C. (2003) · Autoimmunity Reviews · doi:10.1016/s1568-9972(03)00006-5 · Cited by 880
Bledsoe, R. K., Montana, V. G., Stanley, T. B., Delves, C. J., Apolito, C. J., McKee, D. D., Consler, T. G., Parks, D. J., Stewart, E. L., Willson, T. M., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00817-6 · Cited by 818
McKay, L. I., & Cidlowski, J. A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0375 · Cited by 805
Self-citationFeast and Famine: Critical Role of Glucocorticoids with Insulin in Daily Energy Flow
Dallman, M. F., Strack, A. M., Akana, S. F., Bradbury, M. J., Hanson, E. S., Scribner, K. A., & Smith, M. (1993) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1993.1010 · Cited by 796
Glucocorticoids and invasive fungal infections
Lionakis, M. S., & Kontoyiannis, D. P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14904-5 · Cited by 669
Evolution of the nuclear receptor gene superfamily.
Laudet, V., Hänni, C., Coll, J., Catzeflis, F., & Stéhelin, D. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05139.x · Cited by 666
Riedemann, N. C., Guo, R., & Ward, P. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19523 · Cited by 624
Hafezi-Moghadam, A., Simoncini, T., Yang, Z., Limbourg, F. P., Plumier, J.-C., Rebsamen, M. C., Hsieh, C.-M., Chui, D.-S., Thomas, K. L., Prorock, A. J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-473 · Cited by 594
Nissen, R. M., & Yamamoto, K. R. (2000) · Genes & Development · doi:10.1101/gad.827900 · Cited by 559
Systemic and Local Regulation of the Growth Plate
van der Eerden, B. C. J., Karperien, M., & Wit, J. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0033 · Cited by 558
Riedemann, N. C., Guo, R., & Ward, P. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319523 · Cited by 502
Neuroendocrine aspects of the response to stress
Miller, D. B., & O'Callaghan, J. P. (2002) · Metabolism · doi:10.1053/meta.2002.33184 · Cited by 491
Webster, J. C., Oakley, R. H., Jewell, C. M., & Cidlowski, J. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121455098 · Cited by 482
Self-citationGlucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1
Kassel, O. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.7108 · Cited by 479
Schäcke, H., Schottelius, A., Döcke, W.-D., Strehlke, P., Jaroch, S., Schmees, N., Rehwinkel, H., Hennekes, H., & Asadullah, K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0300372101 · Cited by 466
Plasma binding proteins as mediators of corticosteroid action in vertebrates
Breuner, C., & Orchinik, M. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750099 · Cited by 457
Lu, N. Z., & Cidlowski, J. A. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.025 · Cited by 455
Self-citationCyclooxygenase isozymes and their gene structures and expression
Tanabe, T., & Tohnai, N. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00024-2 · Cited by 422
Mechanisms of Glucocorticoid Action in Bone
CANALIS, E., & DELANY, A. M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04204.x · Cited by 406
Wallace, A. D., & Cidlowski, J. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106033200 · Cited by 394
Self-citationLasa, M., Abraham, S. M., Boucheron, C., Saklatvala, J., & Clark, A. R. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.22.7802-7811.2002 · Cited by 382
Rapid Actions of Steroid Receptors in Cellular Signaling Pathways
Cato, A. C. B., Nestl, A., & Mink, S. (2002) · Science's STKE · doi:10.1126/stke.2002.138.re9 · Cited by 369
Kauppi, B., Jakob, C., Färnegårdh, M., Yang, J., Ahola, H., Alarcon, M., Calles, K., Engström, O., Harlan, J., Muchmore, S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212711200 · Cited by 336
Transcription factors and asthma
Barnes, P., & Adcock, I. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.12010221 · Cited by 320
Modulation of Glucocorticoid Receptor Function via Phosphorylation
ISMAILI, N., & GARABEDIAN, M. J. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1321.007 · Cited by 318
Glucocorticoids and Vascular Reactivity
Yang, S., & Zhang, L. (2004) · Current Vascular Pharmacology · doi:10.2174/1570161043476483 · Cited by 308
The role of corticosteroids in the regulation of vascular tone
Ullian, M. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00230-2 · Cited by 260
Regulatory Mechanism and Physiological Role of Cytosolic Phospholipase A2
Hirabayashi, T., Murayama, T., & Shimizu, T. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.1168 · Cited by 240
Allen, D. B., Bielory, L., Derendorf, H., Dluhy, R., Colice, G. L., & Szefler, S. J. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(03)01859-1 · Cited by 231
Negative Glucocorticoid Receptor Response Elements and their Role in Glucocorticoid Action
A., D., & T., H. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383601 · Cited by 225
McKay, L. I. (1999) · Endocrine Reviews · doi:10.1210/er.20.4.435 · Cited by 223
The Origin and Functions of Multiple Human Glucocorticoid Receptor Isoforms
LU, N. Z., & CIDLOWSKI, J. A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1321.008 · Cited by 216
Self-citationRivest, S. (2001) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00064-6 · Cited by 196
Holmstrom, S. R., Antwerp, M. E. V., & Iñiguez-Lluhí, J. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2136933100 · Cited by 175
Lim, L. H. K., Solito, E., Russo-Marie, F., Flower, R. J., & Perretti, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14535 · Cited by 167
Molecular Identification and Characterization of A and B Forms of the Glucocorticoid Receptor
Yudt, M. R. (2001) · Molecular Endocrinology · doi:10.1210/me.15.7.1093 · Cited by 164
Self-citationReview of the Molecular and Cellular Mechanisms of Action of Glucocorticoids for Use in Asthma
Umland, S. P., Schleimer, R. P., & Johnston, S. L. (2002) · Pulmonary Pharmacology & Therapeutics · doi:10.1006/pupt.2001.0312 · Cited by 159
Potentiation of glucocorticoid receptor transcriptional activity by sumoylation
Le Drean, Y., Mincheneau, N., Le Goff, P., & Michel, D. (2002) · Endocrinology · doi:10.1210/en.2002-220135 · Cited by 159
Different glucocorticoids vary in their genomic and non‐genomic mechanism of action in A549 cells
Croxtall, J. D., van Hal, P. T. W., Choudhury, Q., Gilroy, D. W., & Flower, R. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704474 · Cited by 157
Multiple Variable First Exons: A Mechanism for Cell- and Tissue-Specific Gene Regulation
Zhang, T., Haws, P., & Wu, Q. (2003) · Genome Research · doi:10.1101/gr.1225204 · Cited by 156
Chrysis, D., Zaman, F., Chagin, A. S., Takigawa, M., & Savendahl, L. S. (2004) · Endocrinology · doi:10.1210/en.2004-1152 · Cited by 153
Regulation of Leukocyte‐Endothelial Interactions by Glucocorticoids
Pitzalis, C., Pipitone, N., & Perretti, M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04208.x · Cited by 152
The Microcirculation and Inflammation: Site of Action for Glucocorticoids
Perretti, M., & Ahluwalia, A. (2000) · Microcirculation · doi:10.1111/j.1549-8719.2000.tb00117.x · Cited by 150
Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells
Tsitoura, D. C., & Rothman, P. B. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18975 · Cited by 146
Control of the expression of inflammatory response genes
Saklatvala, J., Dean, J. L. E., & Clark, A. R. (2003) · Biochemical Society Symposia · doi:10.1042/bss0700095 · Cited by 144
Cardiovascular and renal control in NOS-deficient mouse models
Ortiz, P. A., & Garvin, J. L. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00401.2002 · Cited by 132
Li, L.-B., Goleva, E., Hall, C. F., Ou, L.-S., & Leung, D. Y. M. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.08.005 · Cited by 127
Garside, H., Stevens, A., Farrow, S. N., Normand, C., Houle, B., Berry, A., Maschera, B., & Ray, D. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407309200 · Cited by 123
Chromatin remodeling by nuclear receptors
Hebbar, P. B., & Archer, T. (2003) · Chromosoma · doi:10.1007/s00412-003-0232-x · Cited by 117
Glucocorticoid-regulated gene expression during cutaneous wound repair
BEER, H.-D., Fässler, R., & Werner, S. (2000) · Vitamins & Hormones · doi:10.1016/s0083-6729(00)59008-6 · Cited by 113
Pujols, L., Mullol, J., Pérez, M., Roca‐Ferrer, J., Juan, M., Xaubet, A., Cidlowski, J. A., & Picado, C. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.1.4024 · Cited by 113
Self-citationRichardson, D. W., & Dodge, G. R. (2003) · Inflammation Research · doi:10.1007/s000110300012 · Cited by 113
Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells
Tsitoura, D. C., & Rothman, P. B. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200418975 · Cited by 112
Influence of Cortisol Status on Leptin Secretion
Leal‐Cerro, A., Soto, A., Martínez, M. A., Diéguez, C., & Casanueva, F. F. (2001) · Pituitary · doi:10.1023/a:1012903330944 · Cited by 104
Chikanza, I. C. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04200.x · Cited by 103
KAPCALA, L. P., CHAUTARD, T., & ESKAY, R. L. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44699.x · Cited by 103
Systemic Inflammation‐Associated Glucocorticoid Resistance and Outcome of ARDS
Meduri, G. U., & Yates, C. R. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1321.004 · Cited by 98
Inhibition of Cytosolic Phospholipase A2 by Annexin I
Kim, S. W., Rhee, H. J., Ko, J., Kim, Y. J., Kim, H. G., Yang, J. M., Choi, E. C., & Na, D. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009905200 · Cited by 91
How is Type I procollagen synthesis regulated at the gene level during tissue fibrosis
Cutroneo, K. R. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10599 · Cited by 91
Glucocorticoids, Transmitters and Stress
Delbende, C., Delarue, C., Lefèbvre, H., Bunel, D. T., SZAFARCZYK, A., Mocaër, E., Kamoun, A., Jégou, S., & Vaudry, H. (1992) · The British Journal of Psychiatry · doi:10.1192/s0007125000296657 · Cited by 90
The annexin-1 knockout mouse: what it tells us about the inflammatory response.
Roviezzo, F., Getting, S. J., Paul‐Clark, M. J., Yona, S., Gavins, F. N. E., Perretti, M., Hannon, R., Croxtall, J. D., Buckingham, J. C., & Flower, R. J. (2002) · PubMed · Cited by 82
Management of patients on chronic glucocorticoid therapy: an endocrine perspective
Trence, D. (2003) · Primary Care Clinics in Office Practice · doi:10.1016/s0095-4543(03)00038-1 · Cited by 79
Solito, E., de Coupade, C., Parente, L., Flower, R. J., & Russo‐Marie, F. (1998) · Cytokine · doi:10.1006/cyto.1997.0325 · Cited by 77
Toh, M., Yang, Y. H., Leech, M. T., Santos, L., & Morand, E. F. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20580 · Cited by 70
Is there an inhibitory effect of COX-2 inhibitors on bone healing?
Seidenberg, A. B. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2003.12.017 · Cited by 67
Pedersen, K. B., & Vedeckis, W. V. (2003) · Biochemistry · doi:10.1021/bi034651u · Cited by 64
Nuutinen, P., Riekki, R., Parikka, M., Salo, T. A., Autio, P., Risteli, J., & Oikarinen, A. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05018.x · Cited by 62
Effect of an Inhaled Glucocorticosteroid on Airway Mucosal Blood Flow in Mild Asthma
Brieva, J. L., Danta, I., & Wanner, A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.1.9905068 · Cited by 59
Gille, J., Reisinger, K., Westphal-Varghese, B., & Kaufmann, R. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01573.x · Cited by 57
The Pursuit of Differentiated Ligands for the Glucocorticoid Receptor
Coghlan, M. J., Elmore, S., Kym, P. R., & Kort, M. E. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033451718 · Cited by 54
Glucocorticoid Receptor Isoforms α and β in in Vitro Cytokine-induced Glucocorticoid Insensitivity
Torrego, A., Pujols, L., Roca-Ferrer, J., Mullol, J., Xaubet, A., & Picado, C. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200308-1143oc · Cited by 53
Mulla, A., le Roux, C. W., Solito, E., & Buckingham, J. C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1230 · Cited by 50
Subnuclear Trafficking and Gene Targeting by Steroid Receptors
Nagaich, A. K., Rayasam, G. V., Martinez, E. D., BECKER, M., Qiu, Y., Johnson, T. A., Elbi, C., Fletcher, T. M., John, S., & Hager, G. L. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1321.002 · Cited by 50
Bladh, L.-G., Lidén, J., Dahlman-Wright, K., Reimers, M., Nilsson, S., & Okret, S. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.005801 · Cited by 49
Wang, X., Pongrac, J. L., & DeFranco, D. B. (2002) · Molecular Endocrinology · doi:10.1210/me.2001-0287 · Cited by 48
Adrenergic airway vascular smooth muscle responsiveness in healthy and asthmatic subjects
Brieva, J. L., & Wanner, A. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.90.2.665 · Cited by 46 · cited 1×
“Patients with asthma have a normal response to b2-agonists in terms of the relaxation of bronchial smooth muscles and increased flow rates, but they have an elevated baseline level of mucosal blood flow that is hypersensitive to vasoconstriction by a1-agonists and insensitive to further vasodilation by b2-agonists.(64…”
BackgroundIs there a role for glucocorticoid receptor beta in asthma?
Gagliardo, R. P., Vignola, A. M., & Mathieu, M. N. (2000) · Respiratory Research · doi:10.1186/rr31 · Cited by 34
Mizuno, H., Uemura, K., Moriyama, A., Wada, Y., Asai, K., Kimura, S., & Kato, T. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01259-0 · Cited by 29
Comparison between the Effects of Dexamethasone and Indomethacin on Bone Wound Healing
Sato, S., Takashi, K. I. M., Toshiaki, A. R. A. I., Maruyama, S., Tajima, M., & Utsumi, N. (1986) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.42.71 · Cited by 27
CREB is involved in mouse annexin A1 regulation by cAMP and glucocorticoids
Antonicelli, F. D., de Coupade, C., Russo‐Marie, F., & Garrec, Y. L. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01840.x · Cited by 25
Einstein, M., Greenlee, M. L., Rouen, G. P., Sitlani, A., Santoro, J., Wang, C., Pandit, S., Mazur, P., Smalera, I., Weaver, A. P., et al. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.10.009 · Cited by 23
Mechanisms accelerating muscle atrophy in catabolic diseases.
Mitch, W. E. (2000) · PubMed Central · Cited by 16
Expected characteristics of an ideal, all-purpose inhaled corticosteroid for the treatment of asthma
Kemp, J. D. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80303-x · Cited by 7
Nuclear Factor-κB and Glucocorticoid Receptors
Rhen, T., & Cidlowski, J. A. (2004) · Elsevier eBooks · doi:10.1016/b0-12-475570-4/00931-8 · Cited by 6
Self-citation
Research works printed but not linked: 4
- Rhen T, Cidlowski JA. Steroid hormone action. In: Strauss JF III, Barbieri RL, eds. Yen and Jaffe's reproductive endocrinology. 5th ed. Philadelphia: Elsevier Saunders, 2004:155-74.
- 10.1210/mend.15.7.0667 · doi:10.1210/mend.15.7.0667 · Paper page
- Roviezzo F, 2002, J Physiol Pharmacol, 53, 541
- Mitch WE, 2000, Trans Am Clin Climatol Assoc, 111, 258
Cited by
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
“Regarding the HPA axis, cortisol is one of the most potent anti-inflammatory hormones in the body (58); yet, in the context of chronic stress or depression, as noted above, the immune system can become glucocorticoid resistant.”
Development, maintenance and disruption of the blood-brain barrier
Obermeier, B., Daneman, R., & Ransohoff, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3407 · Cited by 2,452
Slavich, G. M., & Irwin, M. R. (2014) · Psychological Bulletin · doi:10.1037/a0035302 · Cited by 2,206
“It is therefore a prototype for some of the most effective anti-inflammatory drugs (Pace, Hu, & Miller, 2007; Rhen & Cidlowski, 2005).”
BackgroundCoutinho, A. E., & Chapman, K. E. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.04.005 · Cited by 1,815
“…1 r ( s t t s g n a A.E. Coutinho, K.E. Chapman / Molecula eviewed; Perretti and Ahluwalia (2000), Necela and Cidlowski 2004), Yeager et al. (2004), Rhen and Cidlowski (2005), Smoak nd Cidlowski (2004), Tuckermann et al. (2005), Kleiman and uckermann (2007), Newton and Holden (2007) and De…”
Metadata
- Authors
- Rhen, T., & Cidlowski, J. A.
- Affiliations
- National Institutes of Health (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-10-20
- Volume
- 353
- Issue
- 16
- Pages
- 1711-1723
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2150691073
- Cited by
- 3,149
- References
- 93
- Citations by year
- 2026: 123 · 2025: 122 · 2024: 152 · 2023: 155 · 2022: 188 · 2021: 220 · 2020: 214 · 2019: 164 · 2018: 153 · 2017: 173 · 2016: 183 · 2015: 176 · 2014: 163 · 2013: 167 · 2012: 136
- FWCI
- 9.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- glucocorticoids, anti-inflammatory mechanism, inflammation, glucocorticoid adverse effects, drug mechanisms of action
- MeSH terms
- Anti-Inflammatory Agents, Glucocorticoids, Humans, Inflammation, Receptors, Glucocorticoid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.